1819-KL) and heparin (10 µg/mL), Recombinant Human FGF-23 (Catalog #
2604-FG) stimulates proliferation in the NIH-3T3 mouse embryonic fibroblast cell line in a dose-dependent manner (orange line). Under these conditions, proliferation elicited by Recombinant Human FGF-23 (1 µg/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Human FGF-23 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2604). The ND
50 is typically 5-15 µg/mL." class="big_lightbox">

1819-KL) and heparin (10 µg/mL), Recombinant Human FGF-23 (Catalog #
2604-FG) stimulates proliferation in the NIH-3T3 mouse embryonic fibroblast cell line in a dose-dependent manner (orange line). Under these conditions, proliferation elicited by Recombinant Human FGF-23 (1 µg/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Human FGF-23 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2604). The ND
50 is typically 5-15 µg/mL." alt="In the presence of Recombinant Mouse Klotho (5 µg/mL, Catalog #
1819-KL) and heparin (10 µg/mL), Recombinant Human FGF-23 (Catalog #
2604-FG) stimulates proliferation in the NIH-3T3 mouse embryonic fibroblast cell line in a dose-dependent manner (orange line). Under these conditions, proliferation elicited by Recombinant Human FGF-23 (1 µg/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Human FGF-23 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2604). The ND
50 is typically 5-15 µg/mL." class="big_thumb" />